| 000 | 01180 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517134923.0 | ||
| 264 | 0 | _c20180504 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1558-4410 | ||
| 024 | 7 |
_a10.1016/j.ecl.2016.09.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhan, Moin | |
| 245 | 0 | 0 |
_aDrug-Related Adverse Events of Osteoporosis Therapy. _h[electronic resource] |
| 260 |
_bEndocrinology and metabolism clinics of North America _c03 2017 |
||
| 300 |
_a181-192 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadverse effects |
| 650 | 0 | 4 |
_aDenosumab _xadverse effects |
| 650 | 0 | 4 |
_aDiphosphonates _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFractures, Bone _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdrug therapy |
| 650 | 0 | 4 |
_aTeriparatide _xadverse effects |
| 700 | 1 | _aCheung, Angela M | |
| 700 | 1 | _aKhan, Aliya A | |
| 773 | 0 |
_tEndocrinology and metabolism clinics of North America _gvol. 46 _gno. 1 _gp. 181-192 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ecl.2016.09.009 _zAvailable from publisher's website |
| 999 |
_c26826482 _d26826482 |
||